| Filed On | Filing |
|---|---|
| 12 Nov 2026 | SCHEDULE 13G |
| 28 Oct 2026 | 425 |
| 28 Oct 2026 |
8-K: Results of Operations and Financial Condition; Regulation FD Disclosure
Disclaimer & Cautionary Statements This presentation and our earnings call includes forward-looking statements. Forward-looking statements are subject to risks and uncertainties, and the Company cautions investors against placing undue r... |
| 28 Oct 2026 | 10-Q |
| 16 Oct 2026 | CURRENT REPORT |
| 16 Oct 2026 |
8-K: Other Events
As previously announced, MiMedx Group, Inc., a Florida corporation (the “Company”), entered into an Agreement and Plan of Merger (the “Merger Agreement”) with Sanara MedTech Inc., a Texas corporation (“Sanara”), and Mustang Merger Sub, I... |
| 04 Sep 2026 | EFFECT |
| 04 Sep 2026 | PROSPECTUS |
| 25 Aug 2026 | REGISTRATION STATEMENT |
| 11 Aug 2026 | 425 |
| 11 Aug 2026 |
8-K/A: Entry into a Material Definitive Agreement; Regulation FD Disclosure
On July 29, 2026, MiMedx Group, Inc., a Florida corporation ( “MiMedx”), entered into an Agreement and Plan of Merger (the “Merger Agreement”) with Sanara MedTech Inc., a Texas corporation (“Sanara”), and Mustang Merger Sub, Inc., a whol... |
| 30 Jul 2026 | FORM 425 |
| 30 Jul 2026 | FORM 425 |
| 29 Jul 2026 | FORM 425 |
| 29 Jul 2026 | FORM 425 |
| 29 Jul 2026 | 425 |
| 29 Jul 2026 |
8-K: Results of Operations and Financial Condition; Regulation FD Disclosure
Reiterates Full Year Financial Outlook on a Standalone Basis |
| 29 Jul 2026 | 425 |
| 29 Jul 2026 | 10-Q |
| 29 Jul 2026 |
8-K: Entry into a Material Definitive Agreement; Regulation FD Disclosure
AGREEMENT AND PLAN OF MERGERdated as ofJuly 29, 2026amongSANARA MEDTECH INC.,MIMEDX GROUP, INC.andMUSTANG MERGER SUB, INC. |
Loading...